Skip to content
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Breaking news in hematology-oncology
The American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, was held on the 1–4 December.
Explore the news from big trials, updates from key pivotal studies, exciting discoveries in disease biology, as well as the latest CAR T-cell data and MRD insights, and late-breaking abstracts.
Breaking Data
Watch the press briefs and late-breaking abstracts.
Big trials with big results, new and novel agents, CAR T-cell therapies, non-malignant pathologies, and more.
View more
CAR T-cells
The latest CAR T-cell data is here, and we’re seeing lots of new exciting agents on the horizon.
Find out all the news from recently approved treatments, as well as the most promising new CARs in the hematology arena, here.
View more
Measurable Residual Disease
The assessment of MRD status has gone from strength to strength.
At ASH we spoke to world-leading experts about the latest on MRD-guided treatment, NGS vs. MFC for measurement, and more.
View more
Sickle Cell Disease & β-Thalassemia
View all
Mohamad and Saad’s ASH Takeaway
Your definitive guide to multiple myeloma at ASH 2018.
Covering the latest trial data, transplant updates, MRD, CAR-T and BiTEs, promising novel agents, and beyond.
View more